{ "results": [ { "id": "12c426bffa80a5b6691ae9ac9fc7b160", "title": "Clinical Trial Manager", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 145000, "salary_max": 160000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 145000, "base_salary_max": 160000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-02T16:46:31.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5098120007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Clinical Trial Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Trial Manger (CTM) to join our growing Clinical Operations team! In", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 5, "years_experience_max": 9, "role_function": "healthcare", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 35, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.d200e99e05d87497d0", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Trial Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Trial Manger (CTM) to join our growing Clinical Operations team! In", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.db3ac9f3ed290255af", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Trial Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Trial Manger (CTM) to join our growing Clinical Operations team! In", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.eecb07717e5a2e4897", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Trial Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Trial Manger (CTM) to join our growing Clinical Operations team! In", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.348b0b4423d72878af", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9c5e81be08d508e8ae", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a6855db1fddf07a222", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12c426bffa80a5b6691ae9ac9fc7b160:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.b7ad655617a9efbb3b", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:d3c0ca70e2a68284b9ecd461", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3240f1c2395e23e128", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.728d0017de9660f93a", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ae5bc09d5512a0b603", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.57b63ec5c5319473da", "query_id": "gq_1286b48453299a8c1338", "job_id": "12c426bffa80a5b6691ae9ac9fc7b160", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "783212903884625e654b1bf74cea3501", "title": "Therapeutic Area Head – Respiratory", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 395000, "salary_max": 425000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 395000, "base_salary_max": 425000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-11T13:34:30.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5160938007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Therapeutic Area Head – Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Therapeutic Area (TA) Head, Respiratory - Clinical Development. In this", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "mid", "years_experience_min": 3, "years_experience_max": 7, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 25, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.25310199dab05de4fd", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Therapeutic Area Head – Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Therapeutic Area (TA) Head, Respiratory - Clinical Development. In this", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.796396ab68f468558c", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Therapeutic Area Head – Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Therapeutic Area (TA) Head, Respiratory - Clinical Development. In this", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c5890c13396bb7d2f2", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Therapeutic Area Head – Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Therapeutic Area (TA) Head, Respiratory - Clinical Development. In this", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0e5c0067f0612ba594", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0f5fa7e2c52792fa8e", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.552d8e85f5d18e69dd", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:783212903884625e654b1bf74cea3501:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2545c0100ba209ba0e", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:d07a677fa7762387213da02d", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.19304284e62f1f7dc1", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2f1b07cb9d7e9a68c3", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4c37bd739ae5036b38", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.5341c9bfb8514c2ce9", "query_id": "gq_1286b48453299a8c1338", "job_id": "783212903884625e654b1bf74cea3501", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "9758f24faca850ae4c9a4ef310b8970f", "title": "Clinical Monitoring Manager", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 150000, "salary_max": 170000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 150000, "base_salary_max": 170000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-02T16:03:41.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5052304007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Clinical Monitoring Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Monitoring Manager to oversee in-house Oversight CRAs that will oversee CRO", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 35, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.2a344b87b17a62d9a0", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Monitoring Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Monitoring Manager to oversee in-house Oversight CRAs that will oversee CRO", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.aad9e2e281d937ccbb", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Monitoring Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Monitoring Manager to oversee in-house Oversight CRAs that will oversee CRO", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ebc291f6e2f4a1146c", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Clinical Monitoring Manager Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Clinical Monitoring Manager to oversee in-house Oversight CRAs that will oversee CRO", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1f9e8fde09489fde8d", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7117f5788aeda606cb", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e9509642a0b1952356", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:9758f24faca850ae4c9a4ef310b8970f:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.5f3521d29b8a7ae0dc", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a65d2ccb5659ce404a56ce4a", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3d67f576c63f7c131e", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.64bca765b48316f649", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.aef50af9f7faea4b2b", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.7f3037afd2b2d46bef", "query_id": "gq_1286b48453299a8c1338", "job_id": "9758f24faca850ae4c9a4ef310b8970f", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "481aede7edc64ef1b5fc8fc0ffa01609", "title": "Senior Associate, Regulatory Affairs", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 120000, "salary_max": 135000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 120000, "base_salary_max": 135000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-06T16:11:33.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5130456007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Associate, Regulatory Affairs Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Senior Associate, Regulatory Affairs. This newly created role offers an opportunity", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 2, "years_experience_max": 6, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 10, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.210bcb7f0f0e29d7bf", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Associate, Regulatory Affairs Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Senior Associate, Regulatory Affairs. This newly created role offers an opportunity", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.3ae3365964a54c3dc5", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Associate, Regulatory Affairs Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Senior Associate, Regulatory Affairs. This newly created role offers an opportunity", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.6a672302c823bb1baa", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Associate, Regulatory Affairs Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Senior Associate, Regulatory Affairs. This newly created role offers an opportunity", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.240bf754f86a0b69a2", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.49cf604ab37ef08781", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ce2a4d810ced27fbd8", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:481aede7edc64ef1b5fc8fc0ffa01609:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2cdc23660045ac152c", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:058484cf628ea306d7ce5a69", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.127262feb9e0aafa36", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.981764b2dd0fc2c838", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f8e2409cda4cc7ed6d", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.8e760c193b1634b313", "query_id": "gq_1286b48453299a8c1338", "job_id": "481aede7edc64ef1b5fc8fc0ffa01609", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "55c55d039c1430de98950e1476bf7361", "title": "Senior Manager, Medical Writing", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 160000, "salary_max": 180000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 160000, "base_salary_max": 180000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-08T13:20:10.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5132727007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Medical Writing Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced and motivated medical writer who is responsible for providing clinical", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0adbb17ddd797bf284", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Medical Writing Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced and motivated medical writer who is responsible for providing clinical", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ce4e7f20fb600df90e", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Medical Writing Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced and motivated medical writer who is responsible for providing clinical", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.f68b7eb13476068aff", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Medical Writing Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced and motivated medical writer who is responsible for providing clinical", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.344d649cbe7e73d9d7", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6db1bdcb3155333352", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a577190994e03cfbc4", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:55c55d039c1430de98950e1476bf7361:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.649584aa0b35a0776d", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:2c8249dfbe9dc18a7f11a968", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9eb2fc6e0098f77e47", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a30dddee0247318fc0", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c04a17e380f433600e", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.d698993f9d6ffa4ead", "query_id": "gq_1286b48453299a8c1338", "job_id": "55c55d039c1430de98950e1476bf7361", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "title": "Medical Science Liaison - Respiratory", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 210000, "salary_max": 235000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 210000, "base_salary_max": 235000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-15T13:36:50.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5138739007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Medical Science Liaison - Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Medical Science Liaison (MSL) with expertise in asthma and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "mid", "years_experience_min": 3, "years_experience_max": 7, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 40, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.4b2727766080934c03", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison - Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Medical Science Liaison (MSL) with expertise in asthma and", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.90c8d3c678e6e2e829", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison - Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Medical Science Liaison (MSL) with expertise in asthma and", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fcd1d418eb6805e58b", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison - Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Medical Science Liaison (MSL) with expertise in asthma and", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.070df4fd059fd1ad76", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a8aedebe083a1c296e", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e721ad66bbb9f1ece6", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f0e8c18cd3d18c2dd3f981eb88f408a:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.3c52b456a02348bde1", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:745e2b24766c64bc5feb8677", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0d5ee3689bb874c9c3", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3bd867199b82141dd8", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6475649290d46e8b52", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.5a50a0e2eecf0e54f1", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f0e8c18cd3d18c2dd3f981eb88f408a", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "73827096c910f8e177186107f0036b04", "title": "Manager, Clinical Business Operations", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 145000, "salary_max": 160000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 145000, "base_salary_max": 160000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-13T14:27:09.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5078580007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Manager, Clinical Business Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Manager, Clinical Business Operations to join the Clinical Operations team at", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 10, "years_experience_max": 14, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 15, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.13542a14b7323d5255", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Clinical Business Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Manager, Clinical Business Operations to join the Clinical Operations team at", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.617d8b9d1146cbe741", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Clinical Business Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Manager, Clinical Business Operations to join the Clinical Operations team at", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e285f811bb56413d5d", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Clinical Business Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Manager, Clinical Business Operations to join the Clinical Operations team at", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.02483acf700218d8bb", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.623017cdba915263af", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cd45efaf8c7e5ec6cb", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:73827096c910f8e177186107f0036b04:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.9ab261c052de3875ea", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:7681d817f5ffb7f2c22912a7", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.00b6d200d431d55b28", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8ed7dcf013a432550f", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d23037bbc132dbc411", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.76c1025711c8380fd3", "query_id": "gq_1286b48453299a8c1338", "job_id": "73827096c910f8e177186107f0036b04", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "title": "Associate Director, Scientific Communications", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 170000, "salary_max": 195000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 170000, "base_salary_max": 195000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-10T19:11:16.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5161356007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Scientific Communications Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a motivated and experienced Associate Director, Scientific Communications to serve as a", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "marketing", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.4f9afcdb3377421cba", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Scientific Communications Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a motivated and experienced Associate Director, Scientific Communications to serve as a", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.7a0b3d471977166ae9", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Scientific Communications Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a motivated and experienced Associate Director, Scientific Communications to serve as a", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b552a74e5988ad3c30", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Scientific Communications Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a motivated and experienced Associate Director, Scientific Communications to serve as a", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.67b914945308ff4aa3", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9cffd1b7530094f4b4", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c46d6e0c9ed718949d", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7f8579b38dfc9518c4c4d4b7a7f6f31c:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2cf9ef943f6ab0dc7c", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:8a8a82e2c5ffc46f9609f604", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.164d42388504f41ceb", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3eee4b738bd96d6c72", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ca42b53761b3690105", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.e06b2079e558a83cd9", "query_id": "gq_1286b48453299a8c1338", "job_id": "7f8579b38dfc9518c4c4d4b7a7f6f31c", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "b00dae88c8b5868ef3a108ee6bf1a765", "title": "Senior Director, Statistical Programming", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 270000, "salary_max": 295000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 270000, "base_salary_max": 295000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-30T16:44:24.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5125373007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Statistical Programming Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary - Support the statistical programming function by implementing programming processes, standards, and SOPs for clinical", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 15, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.1d41d89bbb43e286d8", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Statistical Programming Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary - Support the statistical programming function by implementing programming processes, standards, and SOPs for clinical", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.74c3fac934d54e5d77", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Statistical Programming Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary - Support the statistical programming function by implementing programming processes, standards, and SOPs for clinical", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.90aa28a4a3135b32fe", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Statistical Programming Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary - Support the statistical programming function by implementing programming processes, standards, and SOPs for clinical", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3d41008a579ac5f822", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.89a070df218d33f954", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b436dad5526e1f1bc5", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b00dae88c8b5868ef3a108ee6bf1a765:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.b387983b15cdde2988", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:f6c15175685f540cc60d0eb2", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b07b878f9b7f9d262a", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d381e09e2e33b50b4a", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f8654d8e8f6c51cac7", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.2154c748f3c9232d36", "query_id": "gq_1286b48453299a8c1338", "job_id": "b00dae88c8b5868ef3a108ee6bf1a765", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "548c83a38762090d650e678fad6015e2", "title": "Senior Manager, Regulatory Affairs Project Management", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 150000, "salary_max": 170000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 150000, "base_salary_max": 170000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-19T13:50:20.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5083978007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Regulatory Affairs Project Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced biotech project manager to optimize planning, execution, and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 5, "years_experience_max": 9, "role_function": "finance", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.14e46177fb9265fba9", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Regulatory Affairs Project Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced biotech project manager to optimize planning, execution, and", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.4b2d4c66d6876c9b65", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Regulatory Affairs Project Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced biotech project manager to optimize planning, execution, and", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bfec69552e1db9a930", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Regulatory Affairs Project Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced biotech project manager to optimize planning, execution, and", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4a1146013f83a4bd69", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7631053737b8aae4bb", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bed0ad0e35bac1cda6", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:548c83a38762090d650e678fad6015e2:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.8d50a9dfae5fb0f14c", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:4262f03a6738acc1a084428d", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7e36379b0c0e18ad95", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a7b8e73cfa41708b71", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e5df7edbcbf390aba2", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.e96a1473542f4a78fa", "query_id": "gq_1286b48453299a8c1338", "job_id": "548c83a38762090d650e678fad6015e2", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "title": "Director, Drug Product Development", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 210000, "salary_max": 235000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 210000, "base_salary_max": 235000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-01-12T19:06:18.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5021986007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Drug Product Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, Drug Product Development to develop protein drug product presentations and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 5, "years_experience_max": null, "role_function": "engineering", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 25, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.083f6edf9db154e7e3", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Drug Product Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, Drug Product Development to develop protein drug product presentations and", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.8b7eea34984ca8d07d", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Drug Product Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, Drug Product Development to develop protein drug product presentations and", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.effe44121dcd2d7d39", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Drug Product Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, Drug Product Development to develop protein drug product presentations and", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4cdee7a33d9cb89a6c", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c60e7ae3a38fb1e150", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ea3555e21ef7106bd7", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:b1271d8e3a38c092f6f0f2e8999bfd4c:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.7e6ddd9dd554a69818", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:0094fcb4585cb3889cc41dca", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.41dc2348a451d4d676", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6daadaf1d06fba33d8", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ecd5c51f0c9fa2f3aa", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.20b67b197f459fd8a7", "query_id": "gq_1286b48453299a8c1338", "job_id": "b1271d8e3a38c092f6f0f2e8999bfd4c", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "1e28e3b527d190ca976035adabd0fd75", "title": "Associate Director, Device Development", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "contract", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 180000, "salary_max": 200000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 180000, "base_salary_max": 200000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-22T18:15:50.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5145512007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Device Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Apogee Therapeutics is seeking an Associate Director, Device Development to join the Technical Operations team", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "engineering", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 25, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.35b96b14becf743980", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Device Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Apogee Therapeutics is seeking an Associate Director, Device Development to join the Technical Operations team", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.8281285171df69fb9c", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Device Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Apogee Therapeutics is seeking an Associate Director, Device Development to join the Technical Operations team", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.9635503509113ede34", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Device Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Apogee Therapeutics is seeking an Associate Director, Device Development to join the Technical Operations team", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.68b2ff5b979ee0ff63", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.68fd134e50f68e782c", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cfe50de488489f821c", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:1e28e3b527d190ca976035adabd0fd75:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.fa98314331def913fc", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a398277d3c3ac1821524fd27", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.06d715f209188b5b7d", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.747747715b7a5b74d0", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.780bddf867c19189a2", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.e6f90cea25d88d9046", "query_id": "gq_1286b48453299a8c1338", "job_id": "1e28e3b527d190ca976035adabd0fd75", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "0699009e97f81237728cd64115491c47", "title": "Senior Manager, Clinical Biomarker Operations", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "contract", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 150000, "salary_max": 170000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 150000, "base_salary_max": 170000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-22T18:05:08.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5117623007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Clinical Biomarker Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking a Clinical Biomarker Operations Sr.", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "senior", "years_experience_min": 5, "years_experience_max": 9, "role_function": "healthcare", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.2a109ee484a4930d47", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Clinical Biomarker Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking a Clinical Biomarker Operations Sr.", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.5b7353325ea09c7795", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Clinical Biomarker Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking a Clinical Biomarker Operations Sr.", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b70d12acbbc1143c1a", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Clinical Biomarker Operations Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking a Clinical Biomarker Operations Sr.", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.966f283fe563bb71fc", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a54033ec7961f723dd", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b31b98141b36624438", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0699009e97f81237728cd64115491c47:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.69219f19bc773017ad", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:557ad38d0b933b403d1535d2", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2a0c144baac491357a", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.82d04dead5102ae69d", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c88433e8a793a09462", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.97c8c1b4e26a34308e", "query_id": "gq_1286b48453299a8c1338", "job_id": "0699009e97f81237728cd64115491c47", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "4bf38e81fd621b7a9e5269659e064fb3", "title": "Associate Director, Inflammation Biology", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Hybrid", "country": "unknown", "employment_type": "unknown", "remote_status": "hybrid", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 2, "timezone_overlap_hours": 3, "salary_min": 185000, "salary_max": 205000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 185000, "base_salary_max": 205000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-02T16:18:22.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5152861007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Inflammation Biology Hybrid About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director , Biology .", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e495a1aaf0bb4d83ce", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Inflammation Biology Hybrid About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director , Biology .", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.f52cc4b5f3cf6527cd", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Inflammation Biology Hybrid About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director , Biology .", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fa221d0237a1eb15d8", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Inflammation Biology Hybrid About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director , Biology .", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3707eb190e3f6c4174", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f34234aeb72de1f4ce", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f6dbd7371a8ade144c", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:4bf38e81fd621b7a9e5269659e064fb3:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.4fd513fc2b7cf497b1", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:69b926abaa317307c4e7e09e", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.24283910c2e8e4c963", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.33b5b7a3fd8d7beede", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bb3ea9ca6a42d22ca4", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.09085f1a3f2e7b747f", "query_id": "gq_1286b48453299a8c1338", "job_id": "4bf38e81fd621b7a9e5269659e064fb3", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "0cd1437919fa06e21f8b6ba947c68e60", "title": "Director, Clinical Development (Clinical Science)", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 230000, "salary_max": 260000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 230000, "base_salary_max": 260000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-15T17:01:09.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5138987007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Clinical Development (Clinical Science) Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced non-MD Clinical Scientist. As a Director in Clinical Development,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 35, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.45627769289ee64b75", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Clinical Development (Clinical Science) Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced non-MD Clinical Scientist. As a Director in Clinical Development,", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.6d4624b9c46c807e77", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Clinical Development (Clinical Science) Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced non-MD Clinical Scientist. As a Director in Clinical Development,", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.d51590e7cc85e20504", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Clinical Development (Clinical Science) Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced non-MD Clinical Scientist. As a Director in Clinical Development,", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a7adb86044e912da87", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e225d290b7634ea91d", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e4ec9076ba3470961a", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:0cd1437919fa06e21f8b6ba947c68e60:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.730b85b6386431c087", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:b81ecab1fda17ba3df19f1f8", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8c0bf0a76c8becabc0", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a86cac114e5d371f1d", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f3165ea911f5d2f0d6", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.a1dc98097108af93ee", "query_id": "gq_1286b48453299a8c1338", "job_id": "0cd1437919fa06e21f8b6ba947c68e60", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "7b0722d1814807a24c817ee61a800227", "title": "Senior Director, Channel Strategy and Patient Support", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 280000, "salary_max": 305000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 280000, "base_salary_max": 305000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-13T19:28:12.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5137040007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Channel Strategy and Patient Support Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Channel Strategy - Conduct market research on distribution strategies and trends within", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "product", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bc01eff8cb2f8af9c5", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Channel Strategy and Patient Support Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Channel Strategy - Conduct market research on distribution strategies and trends within", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bff8ca1cf93ab26533", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Channel Strategy and Patient Support Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Channel Strategy - Conduct market research on distribution strategies and trends within", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c533dc00e6ebb8af58", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Channel Strategy and Patient Support Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary Channel Strategy - Conduct market research on distribution strategies and trends within", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0d40ec240460453fb9", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4c8232e55264d1c36d", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.efddee2054cd6ffdcd", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:7b0722d1814807a24c817ee61a800227:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.8a0d75e870aa5e3860", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:d526a2ce6a055924cf64fb8b", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.287f496bbb97ee9db7", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4f2f7d6a9fb298b8a2", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8786abfa917e0f7e56", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.bd672434d782a0d5ff", "query_id": "gq_1286b48453299a8c1338", "job_id": "7b0722d1814807a24c817ee61a800227", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "d8d28d5ed33580c63690efb161a3fe43", "title": "Director, Insights and Market Development", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 235000, "salary_max": 255000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 235000, "base_salary_max": 255000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T13:42:50.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5137582007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Insights and Market Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Director, Insights and Market Development to serve as a", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.47dc70273c9f10e8c0", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Insights and Market Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Director, Insights and Market Development to serve as a", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b38449f52ae1fdaa76", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Insights and Market Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Director, Insights and Market Development to serve as a", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b7e2f2e0f9e6348139", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Insights and Market Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Director, Insights and Market Development to serve as a", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.20558c5fdae23673aa", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2a22a498a7bf95aeab", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.865d9914a1763422f6", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:d8d28d5ed33580c63690efb161a3fe43:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2ce2646223abe5045c", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:e62d865180df41a321f0e599", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3797074667892014e5", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5cb3a5ee7d9b310b26", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f7b4f67acefd34b29d", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.e4a080c5c9dfef341c", "query_id": "gq_1286b48453299a8c1338", "job_id": "d8d28d5ed33580c63690efb161a3fe43", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "56bc3bce5f07f7d6b77e9aad593ea89e", "title": "Associate Director, Monitoring Oversight Management", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "contract", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 180000, "salary_max": 205000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 180000, "base_salary_max": 205000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2025-12-15T21:46:01.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5005031007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Monitoring Oversight Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associator Director, Monitoring Oversight Management, to manage Apogee's Oversight CRAs", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 10, "years_experience_max": null, "role_function": "finance", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 35, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.4b3b7af280b0ae3b1d", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Monitoring Oversight Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associator Director, Monitoring Oversight Management, to manage Apogee's Oversight CRAs", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.4fa0ce3e537c049c65", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Monitoring Oversight Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associator Director, Monitoring Oversight Management, to manage Apogee's Oversight CRAs", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.6cd5c224620471a035", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Monitoring Oversight Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associator Director, Monitoring Oversight Management, to manage Apogee's Oversight CRAs", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2beba2a020dacff02a", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c8be94ed9ab133c057", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f666e4174c88bbc668", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:56bc3bce5f07f7d6b77e9aad593ea89e:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.7e6f24f1639797a4fd", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:d2dfdd78bd4591b9cb98a681", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.279adbc2ffecec1fad", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c593f97764aa136a44", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f968fd93d2a76c0e1f", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.8e4c6e5af79ce3fb71", "query_id": "gq_1286b48453299a8c1338", "job_id": "56bc3bce5f07f7d6b77e9aad593ea89e", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "389e9c5754a417b93c9e4ef5ca686676", "title": "Associate Director, Biostatistics", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 195000, "salary_max": 225000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 195000, "base_salary_max": 225000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-01-05T23:53:23.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5015149007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Biostatistics Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associate Director of Biostatistics. In this position you will be acting as", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 15, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.2b57e5eb6f10978c12", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biostatistics Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associate Director of Biostatistics. In this position you will be acting as", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.da0035e55d71b618dc", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biostatistics Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associate Director of Biostatistics. In this position you will be acting as", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fd4db94093347cd931", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biostatistics Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an Associate Director of Biostatistics. In this position you will be acting as", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.32dbac62a99cd583df", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6a0de903e5685fe792", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6f3df8134bd392f3ae", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:389e9c5754a417b93c9e4ef5ca686676:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.96a6175c3acfdd0841", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:470cfd4f3bd23e4e89f4ab01", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8b8c09e32307fc5f8d", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f278cedc329d5c97ed", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f91fa3feb442e5aa78", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.a2a464d0c9ffb6af74", "query_id": "gq_1286b48453299a8c1338", "job_id": "389e9c5754a417b93c9e4ef5ca686676", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "12578a3c500a279f6688f066cfd074f0", "title": "Director, Data Management and Systems", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "contract", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 215000, "salary_max": 245000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 215000, "base_salary_max": 245000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-10T19:16:02.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5161364007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Data Management and Systems Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Director of Data Management and Systems (DM) is a strategic and operational leader", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 12, "years_experience_max": null, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.7924c77f331024d727", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Data Management and Systems Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Director of Data Management and Systems (DM) is a strategic and operational leader", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.99a59769c7186188e1", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Data Management and Systems Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Director of Data Management and Systems (DM) is a strategic and operational leader", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bd690b6887cdbd3aff", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Data Management and Systems Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Director of Data Management and Systems (DM) is a strategic and operational leader", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7e457191fb68bcfc57", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b76af680b8477145a8", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e8dd40a1249bf8cca9", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:12578a3c500a279f6688f066cfd074f0:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.23fa00d1237bc44c20", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:dbe1bb6e177f207d0e02ad01", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b11a83f7a05ccc1be7", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d5735efe2de59b20e6", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f926f52e47ce01ff4e", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.fbd013b04da7fe15c2", "query_id": "gq_1286b48453299a8c1338", "job_id": "12578a3c500a279f6688f066cfd074f0", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "2901270fc545c41d3eefe9d37b1debcf", "title": "Director, AI Enablement", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "contract", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 225000, "salary_max": 250000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 225000, "base_salary_max": 250000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T14:42:30.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5141496007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, AI Enablement Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, IT - AI Enablement . In this newly created role, you", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0af0f8b2841726ef2a", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, AI Enablement Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, IT - AI Enablement . In this newly created role, you", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bcae3d9ce03c46f46f", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, AI Enablement Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, IT - AI Enablement . In this newly created role, you", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.d7fdd97c146f89dcab", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, AI Enablement Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Director, IT - AI Enablement . In this newly created role, you", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.268fed6dd3225a860a", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.af9d733b369bb9379a", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cbfab580bb039ef04a", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:2901270fc545c41d3eefe9d37b1debcf:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.7195c77d506cda9ca6", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:c109d65d9faa4aefd471b1a5", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.02536bdc5dcf861405", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8de0ad69419594b082", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d9a9e75ea27ce1867b", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.8eed8e06aba07ecb30", "query_id": "gq_1286b48453299a8c1338", "job_id": "2901270fc545c41d3eefe9d37b1debcf", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "64273d034223ddba3c1a9afd914b1695", "title": "Sr. Medical Director, Gastroenterology", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 350000, "salary_max": 375000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 350000, "base_salary_max": 375000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-18T16:16:29.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5104690007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Sr. Medical Director, Gastroenterology Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Sr. Medical Director to lead the EoE (eosinophilic esophagitis) clinical development", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 25, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0f07ab3ae190710a01", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Sr. Medical Director, Gastroenterology Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Sr. Medical Director to lead the EoE (eosinophilic esophagitis) clinical development", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.183c513be252b6874c", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Sr. Medical Director, Gastroenterology Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Sr. Medical Director to lead the EoE (eosinophilic esophagitis) clinical development", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e05dd8625c78b96422", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Sr. Medical Director, Gastroenterology Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Sr. Medical Director to lead the EoE (eosinophilic esophagitis) clinical development", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.15b94c21917919c0c8", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c954489307809bc161", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ed5858e4d78a6586c2", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:64273d034223ddba3c1a9afd914b1695:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.6858a4f6cb711414c5", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a7e94b03f1c092651f7cfd38", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.255c67193172cf6a7c", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f3977fe457495f1463", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f70a761bfe306174ea", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.972d88f2a1729ec2d7", "query_id": "gq_1286b48453299a8c1338", "job_id": "64273d034223ddba3c1a9afd914b1695", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "63d8a3b948232516be15c1255f0f67e1", "title": "Associate Director, Biomarker Development", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 190000, "salary_max": 210000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 190000, "base_salary_max": 210000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-29T13:07:24.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5148737007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Biomarker Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director, Biomarker Development. This", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "staff_plus", "years_experience_min": 8, "years_experience_max": 12, "role_function": "engineering", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 10, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.01f9ea79220eb76e51", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biomarker Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director, Biomarker Development. This", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.8f602fab292f8a71be", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biomarker Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director, Biomarker Development. This", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.a5a33d691ca35f0eb4", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Biomarker Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary The Department of Research and Translational Medicine is seeking an Associate Director, Biomarker Development. This", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4ff77c713f1f68d75a", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8a49b5ebdc401fc647", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f74d909950bc0d02e9", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:63d8a3b948232516be15c1255f0f67e1:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.3ce76e819932ac7901", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:99e36340229ebe0806f03849", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0d0bb586bd80370971", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3ddc0b610303b362a1", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f015e37e40400388a5", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.44f13ac75b656d8b81", "query_id": "gq_1286b48453299a8c1338", "job_id": "63d8a3b948232516be15c1255f0f67e1", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] }, { "id": "a8f93f61616403a9ffffb610d339cacf", "title": "Medical Science Liaison Dermatology - Northeast", "employer_name": "Apogee Therapeutics Inc", "employer_slug": "apogee-therapeutics-inc", "location_text": "Remote", "country": "unknown", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": 210000, "salary_max": 250000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 210000, "base_salary_max": 250000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "options" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_match_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "k401_contribution_source_fields": [ "SMALL_EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-29T12:34:05.000Z", "apply_url": "https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5149758007", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Medical Science Liaison Dermatology - Northeast Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Key Responsibilities - Clinical Support - Collaborate with the clinical study teams to provide medical", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "seniority": "mid", "years_experience_min": 2, "years_experience_max": 6, "role_function": "data", "employer_industry": null, "employer_size": null, "quality_score": 55, "travel_pct": 75, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.01bd8f4ebeccc30221", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Description: \"apogee\"", "tooltip": "Description matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison Dermatology - Northeast Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Key Responsibilities - Clinical Support - Collaborate with the clinical study teams to provide medical", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:description:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.32d4d74508016d43ae", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Description: \"therapeutics\"", "tooltip": "Description matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison Dermatology - Northeast Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Key Responsibilities - Clinical Support - Collaborate with the clinical study teams to provide medical", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:description:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.83f8778e8b94898e99", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Description: \"inc\"", "tooltip": "Description matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Medical Science Liaison Dermatology - Northeast Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Key Responsibilities - Clinical Support - Collaborate with the clinical study teams to provide medical", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:description:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0d6a64d615984aa8bf", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer matched \"inc\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:employer:inc", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1d3fa7df271c4698fd", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer matched \"apogee\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:employer:apogee", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8e5a48767cc0eb8364", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer matched \"therapeutics\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_1286b48453299a8c1338:a8f93f61616403a9ffffb610d339cacf:employer:therapeutics", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.da623ff371b621c66a", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee therapeutics inc", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:0cdf9e187bf679df5e9ab34a", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.49ed5b1f3be6dc8b95", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"inc\"", "tooltip": "Employer contains \"inc\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "inc", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.57f12fd0436cac842c", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"therapeutics\"", "tooltip": "Employer contains \"therapeutics\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "therapeutics", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6c95f167231785b89c", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "query_match", "display_text": "Employer: \"apogee\"", "tooltip": "Employer contains \"apogee\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Apogee Therapeutics Inc", "matched_input": "apogee", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.trust.k401.d5d15ad87585ea8b5e", "query_id": "gq_1286b48453299a8c1338", "job_id": "a8f93f61616403a9ffffb610d339cacf", "signal_type": "trust_signal", "display_text": "Verified 401(k) evidence", "tooltip": "401(k) value has source evidence and a fresh verification timestamp.", "source_binding": "row_trust_evidence", "source_field": "k401_match", "source_value": "yes", "matched_input": true, "derivation_source": "verified_source_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "trust_source_exists", "counts_for_non_trivial_query": false, "truth_verified": true, "exact": true, "priority": 22, "mobile_priority": 11, "ui": { "icon": "PiggyBank", "tone": "verified", "href": null }, "evidence_source": { "source_url": "https://www.askebsa.dol.gov/FOIA%20Files/2024/Latest/F_SCH_I_2024_Latest.zip", "source_label": "401(k) source", "source_date": "2026-06-13T01:18:42.546Z" } } ] } ], "total": 30, "page": 1, "per_page": 24, "applied_filters": { "q": "Apogee Therapeutics Inc" }, "hidden_unknown_benefits_count": 0, "hidden_quality_floor_count": 0, "quality_floor": "default", "search_profile": { "profile_id": "inv382.d6.pg_textsearch_bge_small_rrf.v1", "bm25_extension": "pg_textsearch", "vector_model": "BAAI/bge-small-en-v1.5", "vector_model_version": "v1.5", "fusion_method": "rrf" }, "explanation_context": { "non_trivial_query": true, "query_terms": [ "apogee", "therapeutics", "inc" ], "active_filter_keys": [], "visible_signal_limit": 3, "visible_trust_limit": 2 }, "event_context": null }